Moreover, patients with MIS present more often neutrophilia and thrombocytopenia than lymphocytopenia and have higher levels of pro-inflammatory biomarkers (e.g. CRP and IL-6) within 48 h from admission compared to patients with COVID-19 [17]. The gene discussed is IL6; the disease is COVID-19.